Xueqing Yao

1.4k total citations · 1 hit paper
51 papers, 635 citations indexed

About

Xueqing Yao is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Xueqing Yao has authored 51 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 22 papers in Molecular Biology and 15 papers in Surgery. Recurrent topics in Xueqing Yao's work include Colorectal and Anal Carcinomas (10 papers), Colorectal Cancer Surgical Treatments (8 papers) and Cancer-related molecular mechanisms research (6 papers). Xueqing Yao is often cited by papers focused on Colorectal and Anal Carcinomas (10 papers), Colorectal Cancer Surgical Treatments (8 papers) and Cancer-related molecular mechanisms research (6 papers). Xueqing Yao collaborates with scholars based in China. Xueqing Yao's co-authors include Chengzhi Huang, Heng Fan, Jian‐Hua Zhu, Junjiang Wang, Yue Zhou, Xuegang Sun, Liang Zhao, Liang Li, Jie Long and Chuan Huang and has published in prestigious journals such as Journal of Clinical Oncology, ACS Nano and Biomaterials.

In The Last Decade

Xueqing Yao

43 papers receiving 631 citations

Hit Papers

Single-cell and spatial transcriptome analysis reveals th... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xueqing Yao China 13 360 230 210 118 103 51 635
Zehua Wang China 13 275 0.8× 187 0.8× 185 0.9× 126 1.1× 103 1.0× 32 562
Xinguo Zhu China 15 410 1.1× 301 1.3× 222 1.1× 145 1.2× 70 0.7× 35 713
Haihua Qian China 17 500 1.4× 311 1.4× 261 1.2× 140 1.2× 100 1.0× 29 828
Guoyin Li China 13 343 1.0× 230 1.0× 156 0.7× 56 0.5× 111 1.1× 35 584
Caroline Contat Switzerland 5 381 1.1× 274 1.2× 169 0.8× 222 1.9× 80 0.8× 5 715
Yingying Liang China 15 426 1.2× 252 1.1× 341 1.6× 170 1.4× 187 1.8× 29 851
Elena Vagia United States 9 226 0.6× 153 0.7× 256 1.2× 82 0.7× 125 1.2× 25 493
Leiguang Ye China 11 382 1.1× 187 0.8× 228 1.1× 199 1.7× 94 0.9× 18 631
Fengzhou Li China 14 302 0.8× 149 0.6× 157 0.7× 93 0.8× 112 1.1× 26 542
Zhuoqing Xu China 13 340 0.9× 198 0.9× 266 1.3× 132 1.1× 102 1.0× 25 629

Countries citing papers authored by Xueqing Yao

Since Specialization
Citations

This map shows the geographic impact of Xueqing Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueqing Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueqing Yao more than expected).

Fields of papers citing papers by Xueqing Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueqing Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueqing Yao. The network helps show where Xueqing Yao may publish in the future.

Co-authorship network of co-authors of Xueqing Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Xueqing Yao. A scholar is included among the top collaborators of Xueqing Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueqing Yao. Xueqing Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Jianlong, Yucheng Zhang, Yongfeng Liu, et al.. (2025). Integrative analysis of bulk and single-cell sequencing reveals TNFSF9 as a potential regulator in microsatellite instability stomach adenocarcinoma. European journal of medical research. 30(1). 214–214.
4.
Liu, Linfeng, Jinghui Li, Guosheng Zhang, et al.. (2025). Efficacy and safety of fruquintinib combined with PD-1 inhibitors in the treatment of refractory metastatic colorectal cancer: a systematic review and meta-analysis. Expert Review of Anticancer Therapy. 25(4). 411–421.
5.
Liu, Zhiyuan, Kaihong Huang, Jiawei Wu, et al.. (2025). Artificial intelligence-based model to predict recurrence after local excision in T1 rectal cancer. European Journal of Surgical Oncology. 51(6). 109717–109717. 4 indexed citations
6.
Li, Jinghui, Linfeng Liu, Jiawei Wu, et al.. (2025). Prognostic and clinicopathological significance of C-reactive protein–albumin–lymphocyte(CALLY) in patients with digestive system neoplasms: a systematic review and meta-analysis. World Journal of Surgical Oncology. 23(1). 114–114. 4 indexed citations
8.
Li, Yunlong, Zhiyuan Liu, Ping Wang, et al.. (2024). Bioengineered Extracellular Vesicles Delivering siMDM2 Sensitize Oxaliplatin Therapy Efficacy in Colorectal Cancer. Advanced Healthcare Materials. 14(6). e2403531–e2403531.
9.
Guan, Ruo‐Yu, Jiawei Wu, Zheng Yuan, et al.. (2024). Poorly controlled type II diabetes mellitus significantly enhances postoperative chemoresistance in patients with stage III colon cancer. World Journal of Gastroenterology. 31(3). 98688–98688. 1 indexed citations
10.
Gao, Yuan, Hongming Li, Ping Wang, Junjiang Wang, & Xueqing Yao. (2023). SIK1 suppresses colorectal cancer metastasis and chemoresistance via the TGF-β signaling pathway. Journal of Cancer. 14(13). 2455–2467. 9 indexed citations
11.
Long, Jie, Liang Li, Zixin Wu, et al.. (2023). Single-cell and spatial transcriptome analysis reveals the cellular heterogeneity of liver metastatic colorectal cancer. Science Advances. 9(24). eadf5464–eadf5464. 104 indexed citations breakdown →
12.
Li, Jinghui, et al.. (2023). Efficacy and safety of apatinib combined with radiotherapy in the treatment of advanced pancreatic cancer: a meta-analysis. World Journal of Surgical Oncology. 21(1). 165–165.
14.
Huang, Chengzhi, Yue Zhou, Qi‐Song Tong, et al.. (2022). Precision medicine-guided co-delivery of ASPN siRNA and oxaliplatin by nanoparticles to overcome chemoresistance of colorectal cancer. Biomaterials. 290. 121827–121827. 23 indexed citations
15.
Zhang, Qing, et al.. (2022). Low-dose orlistat promotes the therapeutic effect of oxaliplatin in colorectal cancer. Biomedicine & Pharmacotherapy. 153. 113426–113426. 24 indexed citations
16.
Gao, Yuan, et al.. (2022). Prognostic value of final pathological stage in colon adenocarcinoma after neoadjuvant chemotherapy: A propensity score-matched study. Frontiers in Surgery. 9. 1022025–1022025. 1 indexed citations
17.
Luo, Yuwen, Deqing Wu, Junjiang Wang, et al.. (2021). Long-term oncological outcomes of low anterior resection for rectal cancer with and without preservation of the left colic artery: a retrospective cohort study. BMC Cancer. 21(1). 171–171. 12 indexed citations
18.
Huang, Chengzhi, Minjia Wang, Junjiang Wang, et al.. (2020). Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer. Biochemical Pharmacology. 189. 114390–114390. 17 indexed citations
19.
Li, Yuan, et al.. (2016). [Mechanism of colon cancer cell apoptosis induced by telocinobufagin: role of oxidative stress and apoptosis pathway].. PubMed. 36(7). 921–6. 8 indexed citations
20.
Fan, Heng, Jianhua Zhu, & Xueqing Yao. (2016). Prognostic significance of B7-H3 expression in patients with colorectal cancer: A meta-analysis. Pakistan Journal of Medical Sciences. 32(6). 1568–1573. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026